Analysis Of Income And Expense [Abstract]

Isofol Medical - Filing #689617

Concept	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue	—	12 797 SEK	—	—	—	—	22 407 SEK	—
Material income and expense [abstract]
Finance income (cost)	—	7 706 SEK	—	—	—	—	4 215 SEK	—
Revenue and other operating income	—	12 856 SEK	—	—	—	—	22 407 SEK	—
Operating expense	—	180 316 SEK	—	—	—	—	226 872 SEK	—
Expenses by nature [abstract]
Classes of employee benefits expense [abstract]
Employee benefits expense	—	34 748 SEK	—	—	—	—	27 721 SEK	—
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	—	1 642 SEK	—	—	—	—	1 596 SEK	—
Other expenses, by nature	—	142 114 SEK	—	—	—	—	196 712 SEK	—
Disclosure of attribution of expenses by nature to their function [text block]	—	—	—	—	—	—	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	- SEK	159 755 SEK	- SEK	159 755 SEK	- SEK	- SEK	200 251 SEK	200 251 SEK